Public procurement notice: Contract Award Notice
Published: 2022-10-28
Buyer: Instituto Aragonés de Ciencias de la Salud
Country: ES
Contract type: Services
Procedure: Open procedure
CPV classification: 32441100 | 32441300 | 33000000 | 33100000 | 33190000
Estimated value: 70812 EUR
Award criteria: The most economic tender
EU fund: Horizon Europe

Technical requirements: This PCP is carried out by Instituto Aragonés de Ciencias de la Salud, lead procurer acting in the name and on behalf of the buyers group in I.1). The applicable national procurement law is Spanish.
Pre-commercial Public Procurement of Comprehensive Services to Patients in Need of Tele-rehabilitation in Isolated Areas, enhanced by Edge Technology, New Care Pathways and Community Support (ROSIA)
The procurement aims to trigger new solutions to be developed and tested to address the following challenge: to unlock the tele-rehabilitation market by purchasing the development of a technological innovation ecosystem, enabling service providers to provide telerehabilitation, and self-management of rehabilitation & self-care at home, at scale. The ecosystem’s design should enable the flexible implementation of a value-based and integrated-care model, enable data driven intervention and the seamless integration of third-party solutions. This PCP procurement is a joint procurement by different procurers across Europe that are all facing the same common challenge and are thus looking for similar solutions (so-called 'buyers group'). More information can be found on the ROSIA PCP website: https://rosia-pcp.eu
Main site or place of performance: at least 50 % of the contracted R&D services on the EU member states or H2020 associated countries.
The procurement will take the form of a pre-commercial procurement (PCP) under which R&D service contracts will be awarded to a number of R&D providers in parallel in a phased approach. This will make it possible to compare competing alternative solutions.
Each selected operator will be awarded a framework agreement that covers 3 R&D phases: solution design, prototyping and validation and testing of a limited set of first products or services.
After each phase, intermediate evaluations will be carried out to progressively select the best of the competing solutions. The contractors with the best-value-for-money solutions will be offered a specific contract for the next phase.
This phase is a feasibility study of the selected technologies and proposals, which aims to verify the technical, economic and organisational feasibility of each company’s offer. The expected output from participating companies is a report describing the results of the feasibility study.
The total budget for the R&D contracts in this phase is EUR 82.645 (excluding VAT) and the maximum budget per R&D contract is EUR 16.529 (excluded VAT). Should there is any leftover from this phase, it will be transferred to the next one. From this sum, it is expected that at least 5 contracts will be awarded. But if there are at least 3, ROSIA PCP could be started. This phase will last for 4 months.
The purpose of this phase is to develop the most promising ideas, shown in Phase 1, into well-defined prototypes. Selected companies will each develop a prototype based on the results of their feasibility study. The aim is to verify to what extent the prototype’s main features meet the functional and performance requirements set in the challenge. Participating companies are expected to deliver a prototype specification and lab demonstration. It is expected that the budget for this phase will be EUR 743.802 (excluding VAT) and the maximum budget per R&D contract will be EUR 247.934 (excluding VAT). Should there is any leftover from this phase, it will be transferred to the next one. From this sum, it is expected that at least 3 bidders will be selected for Phase 2. But if there are at least 2, ROSIA Phase 2 could be started.This phase will last 10 months.
This phase aims to verify and compare the full feature set and performance of different solutions in real-life operational conditions of the targeted public service. Expected output from participating companies includes field testing, field test specification, specification of the final solution, other related technical documentation and an updated cost/benefit evaluation. It is expected that the budget for this phase will be EUR 2.396.695 (excluding VAT) and the maximum budget per R&D contract will be EUR 1.198.347 (excluding VAT). 2 projects will be selected for this phase. This phase will last 14 months.
The selected operators will retain ownership of the intellectual property rights (IPRs) that they generate during the PCP and will be able to use them to exploit the full market potential of the developed solutions i.e. beyond the procurement.
This procurement receives funding from the European Union’s Horizon 2020 Research and Innovation Programme, under grant agreement No 101017606 — ROSIA (see https://rosia-pcp.eu/).The EU has given a grant for this procurement, but is not participating as a contracting authority in the procurement.
Pre-commercial Public Procurement of Comprehensive Services to Patients in Need of Tele-rehabilitation in Isolated Areas, enhanced by Edge Technology, New Care Pathways and Community Support (ROSIA)
The procurement is exempted from the EU public procurement directives (including the EU procurement remedies directives 89/665/EEC and 92/13/EEC — see above) and the national laws that implement them. Publication of this notice in the Official Journal is not to be understood as a waiver of this exemption by the contracting authority.


Winner: ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (CERTH)
Award value: 70812
Number of bids: 10